Published in J Hepatol on June 04, 2016
Chinese expert consensus on multidisciplinary diagnosis and treatment of hepatocellular carcinoma with portal vein tumor thrombus: 2016 edition. Oncotarget (2016) 0.84
Controversies and evidence of hepatic resection for hepatocellular carcinoma. BBA Clin (2016) 0.76
Commentary on the article entitled "hepatocellular carcinoma with macrovascular invasion treated with yttrium-90 radioembolization prior to transplantation". Hepatobiliary Surg Nutr (2017) 0.75
Looking Beyond Sorafenib to Treat Advanced Hepatocellular Carcinoma. J Clin Exp Hepatol (2016) 0.75
Associating liver partition and portal vein ligation for bleeding hepatocellular carcinoma in HBV cirrhosis: a safety strategy. Transl Gastroenterol Hepatol (2017) 0.75
Complete response with sorafenib and transcatheter arterial chemoembolization in unresectable hepatocellular carcinoma. World J Gastroenterol (2016) 0.75
Transcatheter arterial chemoembolization (TACE) versus hepatectomy in hepatocellular carcinoma with macrovascular invasion: a meta-analysis of 1683 patients. J Cancer (2017) 0.75
New macroscopic classification and back-flow thrombectomy for advanced hepatocellular carcinoma with portal vein tumor thrombus invading the contralateral second portal branch. Surg Today (2017) 0.75
New Evidence and Perspectives on the Management of Hepatocellular Carcinoma with Portal Vein Tumor Thrombus. J Clin Transl Hepatol (2017) 0.75
A Review of Non-operative Treatments for Hepatocellular Carcinoma with Advanced Portal Vein Tumor Thrombus. J Clin Transl Hepatol (2017) 0.75
Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology (2006) 3.68
Comparison of the outcomes between an anatomical subsegmentectomy and a non-anatomical minor hepatectomy for single hepatocellular carcinomas based on a Japanese nationwide survey. Surgery (2008) 2.04
Overall survival after transarterial lipiodol infusion chemotherapy with or without embolization for unresectable hepatocellular carcinoma: propensity score analysis. AJR Am J Roentgenol (2010) 1.79
JSH Consensus-Based Clinical Practice Guidelines for the Management of Hepatocellular Carcinoma: 2014 Update by the Liver Cancer Study Group of Japan. Liver Cancer (2014) 1.35
Prognostic impact of spontaneous tumor rupture in patients with hepatocellular carcinoma: an analysis of 1160 cases from a nationwide survey. Ann Surg (2014) 1.25
Comparison of resection and ablation for hepatocellular carcinoma: a cohort study based on a Japanese nationwide survey. J Hepatol (2012) 1.19
Transarterial chemoembolization failure/refractoriness: JSH-LCSGJ criteria 2014 update. Oncology (2014) 1.06
Recurrence-free survival more than 10 years after liver resection for hepatocellular carcinoma. Br J Surg (2011) 1.01
A modified Japan Integrated Stage score for prognostic assessment in patients with hepatocellular carcinoma. J Gastroenterol (2006) 0.97
Effect of hepatic arterial infusion chemotherapy of 5-fluorouracil and cisplatin for advanced hepatocellular carcinoma in the Nationwide Survey of Primary Liver Cancer in Japan. Br J Cancer (2013) 0.97
Surveillance and diagnostic algorithm for hepatocellular carcinoma proposed by the Liver Cancer Study Group of Japan: 2014 update. Oncology (2014) 0.96
A comparison of the surgical outcomes among patients with HBV-positive, HCV-positive, and non-B non-C hepatocellular carcinoma: a nationwide study of 11,950 patients. Ann Surg (2015) 0.94
Validation of serological models for staging and prognostication of HCC in patients from a Japanese nationwide survey. J Gastroenterol (2017) 0.91
Nationwide study of 4741 patients with non-B non-C hepatocellular carcinoma with special reference to the therapeutic impact. Ann Surg (2014) 0.88
Proposal of a new staging system for intrahepatic cholangiocarcinoma: Analysis of surgical patients from a nationwide survey of the Liver Cancer Study Group of Japan. Cancer (2015) 0.85
Survival Analysis over 28 Years of 173,378 Patients with Hepatocellular Carcinoma in Japan. Liver Cancer (2016) 0.83
Response Evaluation Criteria in Cancer of the Liver (RECICL) (2015 Revised version). Hepatol Res (2015) 0.83
Impact of histologically confirmed lymph node metastases on patient survival after surgical resection for hepatocellular carcinoma: report of a Japanese nationwide survey. Ann Surg (2014) 0.78
Demonstration of quality of care measurement using the Japanese liver cancer registry. Hepatol Res (2011) 0.78
Clinical implication of hypovascular hepatocellular carcinoma studied in 4,474 patients with solitary tumour equal or less than 3 cm. Liver Int (2013) 0.75
Survival Benefit of Locoregional Treatment for Hepatocellular Carcinoma with Advanced Liver Cirrhosis. Liver Cancer (2016) 0.75
Venous drainage map of the liver for complex hepatobiliary surgery and liver transplantation. HPB (Oxford) (2016) 0.75
[Liver cancer: progress in diagnosis and treatments. Topics: IV. Progress in guideline on liver cancer; 2. Treatment algorithm and clinical practice guidelines for hepatocellular carcinoma]. Nihon Naika Gakkai Zasshi (2014) 0.75
Abdominal paresthesia resembling restless legs syndrome successfully treated with iron supplement therapy: a case report. J Neurol Sci (2013) 0.75
Predictive value of low serum pancreatic enzymes in invasive intraductal papillary mucinous neoplasms. Pancreatology (2016) 0.75
A multicenter phase II trial evaluating the efficacy of bevacizumab plus mFOLFOX6 for R0 surgical resection in advanced colorectal liver metastases harboring mutant-type KRAS: NEXTO-mt trial. HPB (Oxford) (2022) 0.75
Prospective Study of Trajectories of Physical Performance and Mortality Among Community-Dwelling Older Japanese. J Gerontol A Biol Sci Med Sci (2016) 0.75
Recommendation of treatment strategy for postpancreatectomy hemorrhage: Lessons from a single-center experience in 35 patients. Pancreatology (2016) 0.75
Impact of Advanced Age on Survival in Patients Undergoing Resection of Hepatocellular Carcinoma: Report of a Japanese Nationwide Survey. Ann Surg (2017) 0.75
Association between serum SPan-1 and lymph node metastasis in invasive intraductal papillary mucinous neoplasm of the pancreas. Pancreatology (2016) 0.75
Liver resection for hepatocellular carcinoma associated with hepatic vein invasion: a Japanese nationwide survey. Hepatology (2017) 0.75
[Liver cancer: progress in diagnosis and treatments. Topics: VI. Progress in treatments of liver cancer; 1. Liver resection for hepatocellular carcinoma]. Nihon Naika Gakkai Zasshi (2014) 0.75